Kynam Capital Management, LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $953 Million distributed in 23 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $183M, Syndax Pharmaceuticals Inc with a value of $135M, Celldex Therapeutics, Inc. with a value of $122M, Vera Therapeutics, Inc. with a value of $65.8M, and Cogent Biosciences, Inc. with a value of $57.1M.

Examining the 13F form we can see an increase of $59.1M in the current position value, from $894M to 953M.

Kynam Capital Management, LP is based out at Princeton, NJ

Below you can find more details about Kynam Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $953 Million
Healthcare: $953 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 23
  • Current Value $953 Million
  • Prior Value $894 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.